Ami Fadia
Stock Analyst at Needham
(4.94)
# 156
Out of 4,382 analysts
610
Total ratings
55.6%
Success rate
28.9%
Average return
Main Sectors:
Stocks Rated by Ami Fadia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRAX Praxis Precision Medicines | Maintained: Buy | $537 | $254.00 | +111.42% | 24 | Jun 2, 2026 | |
| IMRX Immuneering | Maintained: Buy | $11 | $4.27 | +157.61% | 31 | Jun 2, 2026 | |
| RVMD Revolution Medicines | Maintained: Buy | $183 | $149.23 | +22.63% | 32 | Jun 1, 2026 | |
| ALKS Alkermes | Maintained: Buy | $50 | $42.80 | +16.82% | 14 | May 28, 2026 | |
| BCYC Bicycle Therapeutics | Maintained: Buy | $15 | $4.19 | +258.00% | 43 | May 22, 2026 | |
| MPLT MapLight Therapeutics | Maintained: Buy | $37 | $28.01 | +32.10% | 4 | May 20, 2026 | |
| GHRS GH Research | Reiterated: Buy | $32 | $21.43 | +49.32% | 5 | May 15, 2026 | |
| BIIB Biogen | Maintained: Hold | n/a | $195.34 | - | 64 | May 14, 2026 | |
| NMRA Neumora Therapeutics | Maintained: Buy | $8 | $1.63 | +390.80% | 18 | May 14, 2026 | |
| ATAI AtaiBeckley | Rated: Buy | $14 → $15 | $3.95 | +279.75% | 9 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $255 | $238.57 | +6.89% | 68 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $163.88 | +22.04% | 43 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $39.62 | - | 9 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 → $38 | $23.55 | +61.36% | 8 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $38 | $21.56 | +76.25% | 37 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 → $45 | $32.20 | +39.75% | 51 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $225 → $267 | $232.32 | +14.93% | 25 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $31.02 | - | 27 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €108.00 | $96.15 | n/a | 8 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $13.56 | n/a | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $7 | $6.18 | n/a | 2 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $15 | $5.56 | n/a | 3 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $15.88 | n/a | 6 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $63 | $10.83 | n/a | 10 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $5.5 → $6 | $13.75 | n/a | 9 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 | $13.93 | n/a | 9 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $75 | $22.75 | n/a | 7 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.00001 | n/a | 5 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $7 | $0.000001 | n/a | 3 | Dec 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $24 | $0.4274 | n/a | 9 | Dec 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 → $1.5 | $0.0501 | n/a | 4 | Oct 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $9 | $13.33 | n/a | 4 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $14 | $34.19 | n/a | 11 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 → $26 | $23.44 | n/a | 7 | Oct 3, 2016 |
Praxis Precision Medicines
Jun 2, 2026
Maintained: Buy
Price Target: $537
Current: $254.00
Upside: +111.42%
Immuneering
Jun 2, 2026
Maintained: Buy
Price Target: $11
Current: $4.27
Upside: +157.61%
Revolution Medicines
Jun 1, 2026
Maintained: Buy
Price Target: $183
Current: $149.23
Upside: +22.63%
Alkermes
May 28, 2026
Maintained: Buy
Price Target: $50
Current: $42.80
Upside: +16.82%
Bicycle Therapeutics
May 22, 2026
Maintained: Buy
Price Target: $15
Current: $4.19
Upside: +258.00%
MapLight Therapeutics
May 20, 2026
Maintained: Buy
Price Target: $37
Current: $28.01
Upside: +32.10%
GH Research
May 15, 2026
Reiterated: Buy
Price Target: $32
Current: $21.43
Upside: +49.32%
Biogen
May 14, 2026
Maintained: Hold
Price Target: n/a
Current: $195.34
Upside: -
Neumora Therapeutics
May 14, 2026
Maintained: Buy
Price Target: $8
Current: $1.63
Upside: +390.80%
AtaiBeckley
May 13, 2026
Rated: Buy
Price Target: $14 → $15
Current: $3.95
Upside: +279.75%
May 11, 2026
Reiterated: Buy
Price Target: $255
Current: $238.57
Upside: +6.89%
May 11, 2026
Reiterated: Buy
Price Target: $200
Current: $163.88
Upside: +22.04%
May 11, 2026
Reiterated: Hold
Price Target: n/a
Current: $39.62
Upside: -
May 8, 2026
Maintained: Buy
Price Target: $28 → $38
Current: $23.55
Upside: +61.36%
May 7, 2026
Reiterated: Buy
Price Target: $40 → $38
Current: $21.56
Upside: +76.25%
May 7, 2026
Reiterated: Buy
Price Target: $44 → $45
Current: $32.20
Upside: +39.75%
May 6, 2026
Reiterated: Buy
Price Target: $225 → $267
Current: $232.32
Upside: +14.93%
May 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $31.02
Upside: -
Apr 25, 2025
Reiterated: Buy
Price Target: €108.00
Current: $96.15
Upside: n/a
Dec 14, 2022
Initiated Coverage: Hold
Price Target: n/a
Current: $13.56
Upside: n/a
Mar 10, 2021
Reiterated: Buy
Price Target: $10 → $7
Current: $6.18
Upside: n/a
Mar 8, 2021
Reiterated: Buy
Price Target: $10 → $15
Current: $5.56
Upside: n/a
Mar 2, 2021
Rated: Hold
Price Target: n/a
Current: $15.88
Upside: n/a
Mar 1, 2021
Rated: Buy
Price Target: $63
Current: $10.83
Upside: n/a
Feb 26, 2021
Rated: Hold
Price Target: $5.5 → $6
Current: $13.75
Upside: n/a
Feb 25, 2021
Rated: Buy
Price Target: $16
Current: $13.93
Upside: n/a
Feb 25, 2021
Rated: Hold
Price Target: $75
Current: $22.75
Upside: n/a
Jan 11, 2021
Reiterated: Buy
Price Target: $5
Current: $0.00001
Upside: n/a
Dec 30, 2020
Maintained: Buy
Price Target: $10 → $7
Current: $0.000001
Upside: n/a
Dec 2, 2020
Maintained: Buy
Price Target: $19 → $24
Current: $0.4274
Upside: n/a
Oct 1, 2020
Maintained: Hold
Price Target: $1 → $1.5
Current: $0.0501
Upside: n/a
Aug 14, 2020
Maintained: Buy
Price Target: $8 → $9
Current: $13.33
Upside: n/a
Aug 6, 2020
Maintained: Hold
Price Target: $12 → $14
Current: $34.19
Upside: n/a
Oct 3, 2016
Maintained: Hold
Price Target: $20 → $26
Current: $23.44
Upside: n/a